Effect of dyslipidemia on HBsAg clearance in nucleos(t)ide analogues-experienced chronic hepatitis B patients treated with peginterferon alfa
Dyslipidemia can affect the antiviral efficacy of PegIFNα in NAs-experienced CHB patients. Our findings suggest that the nomogram model constructed using serum lipid has good predictive power and may help physicians to identify the superior patients for PegIFNα therapy.
Authors
- Yijie Lin (ORCID: https://orcid.org/0000-0001-5979-8940)
- Zhijun Su (ORCID: https://orcid.org/0000-0003-2849-480X)
- Yongjun Zhou (ORCID: https://orcid.org/0000-0003-3716-0641)
- Da‐Wu Zeng (ORCID: https://orcid.org/0000-0003-3818-0062)
- Xueping Yu (ORCID: https://orcid.org/0000-0002-1157-2501)
- H Wang (ORCID: https://orcid.org/0009-0005-3542-1125)
- Lan Zhu Ren
- Kaimin Song (ORCID: https://orcid.org/0000-0003-0312-3535)
- Zhixiang Guo (ORCID: https://orcid.org/0009-0006-1987-2660)
- Huatang Zhang (ORCID: https://orcid.org/0000-0002-6655-2911)
- Yijuan Zheng
- Yunyun Qian
Institutions
- Fujian Medical University (CN)
- Xiamen University (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
- Minnan University of Science and Technology (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1186/s12879-024-10093-w
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province